1. Home
  2. TLSI vs SHMD Comparison

TLSI vs SHMD Comparison

Compare TLSI & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$7.45

Market Cap

244.3M

Sector

Health Care

ML Signal

HOLD

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$5.04

Market Cap

218.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSI
SHMD
Founded
2010
1864
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
244.3M
218.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TLSI
SHMD
Price
$7.45
$5.04
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.50
N/A
AVG Volume (30 Days)
258.1K
180.3K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,207,000.00
$85,165,542.00
Revenue This Year
$55.06
N/A
Revenue Next Year
$46.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
49.52
N/A
52 Week Low
$3.42
$1.86
52 Week High
$7.70
$6.70

Technical Indicators

Market Signals
Indicator
TLSI
SHMD
Relative Strength Index (RSI) 69.62 54.80
Support Level $6.96 $3.87
Resistance Level $7.53 $5.47
Average True Range (ATR) 0.51 0.69
MACD -0.00 -0.04
Stochastic Oscillator 84.86 73.13

Price Performance

Historical Comparison
TLSI
SHMD

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: